Xcout IntelSign inSubscribe
Company directory

Browse companies — page 15 of 35

Every company in Xcout Intel's live graph, 100 at a time. Click through for competitors, funding, hiring signals and more. Back to the companies hub.

ArterisAIP · SemiconductorsCampbell, United States
Public

Arteris, Inc., together with its subsidiaries, provides semiconductor system intellectual property (IP) solutions in the United States, rest of the Americas, China, Korea, the rest of the Asia Pacific, Europe, and the Middle East. It manages on-chip communications and IP block deployments in System-on-Chip (SoC) semiconductors and systems of chiplets. The company offers Network-on-Chip (NoC) IP Products, such as FlexGen, FlexNoC, and FlexWay, a non-coherent NoC IP; Ncore, a cache-coherent NoC IP; and CodaCache, a last-level cache. It also provides hardware security verification software products, such as Cycuity Radix-S to detect and remediate security issues in IP blocks and subsystems of an SoC; Cycuity Radix-M for hardware security verification emulation for system-level SoC and firmware; and Cycuity Radix-ST, a static security analyzer that identifies potential design weaknesses early in the development lifecycle, as well as SoC integration automation software solutions products, including Magillem Connectivity and Registers, and CSRCompiler. In addition, the company offers professional services, such as training, design assistance, and consulting; licensing services for software and intellectual properties; IP support and maintenance; and on-site support services. It serves the automotive, communications, enterprise computing, consumer electronics, and industrial markets. Arteris, Inc. was founded in 2003 and is headquartered in Campbell, California.

Market cap$1.1B
Employees353
Arteris competitors & alternatives →
ClearOne, Inc.CLRO · Audio-Visual ConferencingSalt Lake City, United States
Public

ClearOne, Inc., established in 1983 and headquartered in Salt Lake City, Utah, specializes in the design, development, and sale of advanced communication solutions. The company provides a comprehensive suite of conferencing, collaboration, and network streaming products for both audio and visual interactions, serving markets across the United States and internationally. Its diverse portfolio includes a wide array of audio conferencing technologies. These range from sophisticated professional audio conferencing and sound reinforcement systems tailored for large organizations in sectors like corporate enterprise, healthcare, education (including distance learning), government, legal, and finance, to premium mid-market solutions ideal for smaller meeting spaces and small-to-medium businesses, which are engineered for seamless integration with video and web conferencing platforms. Additionally, ClearOne offers convenient USB-powered speakerphones for individual and group use, compatible with personal and portable electronics such as PCs, laptops, tablets, and smartphones, alongside conventional tabletop conference phones for standard meeting rooms and offices. The company further extends its offerings to video products, encompassing advanced video conferencing and collaboration tools. Complementing these, ClearOne's AV networking solutions facilitate the precise, time-sensitive transmission of high-definition audio, video, and control signals across standard TCP/IP networks, ensuring an optimal IP A/V experience. Furthermore, they provide a selection of professional microphones, including innovative beamforming, ceiling-mounted, and wireless models. ClearOne distributes its commercial products through a broad network that includes independent professional audiovisual, information technology, and telecommunications distributors, as well as system integrators, dealers, value-added resellers, and directly to end-users.

Market cap$7.1M
Employees80
ClearOne, Inc. competitors & alternatives →
Emergent BioSolutions Inc.0IGA · BiopharmaceuticalsGaithersburg, United States
Public

Emergent BioSolutions Inc. is a life sciences enterprise dedicated to developing and delivering solutions for preparing for and responding to diverse public health threats (PHTs) in the United States. Its mission involves countering unforeseen, intentional, and naturally arising health crises affecting populations. The company's product portfolio addresses a wide spectrum of PHTs, encompassing chemical, biological, radiological, nuclear, and explosive agents (CBRNE), emergent infectious diseases, travel-related health concerns, and immediate emergency medical needs. Among its key commercialized offerings are: Vaccines: BioThrax (for anthrax), ACAM2000 (for smallpox), Vivotif (an oral immunization against typhoid fever), and Vaxchora (a single-dose oral vaccine for cholera). Treatments & Antidotes: Botulism Antitoxin Heptavalent (combats botulism), vaccinia immune globulin intravenous (manages adverse reactions to smallpox vaccination), raxibacumab and Anthrasil (both for treating and preventing inhalational anthrax), and NARCAN (a nasal spray for immediate intervention in known or suspected opioid overdoses). Other Emergency Preparedness: Reactive skin decontamination lotion kits, and Trobigard, an investigational auto-injector product combining both drug and device components. Furthermore, Emergent BioSolutions boasts an active development pipeline, featuring candidates such as AP003 (a multidose Naloxone nasal spray), AP007 (a sustained-release Nalmefene injection for opioid use disorder), AV7909 (an anthrax vaccine), CGRD-001 (a pralidoxime chloride/atropine auto-injector), CHIKV VLP (a chikungunya virus-like particle vaccine), COVID-HIG (a treatment for SARS-CoV2), EGRD-001 (a diazepam auto-injector), SIAN (an antidote for acute cyanide poisoning), and UniFlu (a universal influenza vaccine). Beyond its proprietary products, the company also provides comprehensive contract development and manufacturing (CDMO) services. These services include drug substance and product manufacturing, packaging solutions, alongside specialized expertise in technology transfer, process optimization, and analytical development. Established in 1998, Emergent BioSolutions maintains its corporate headquarters in Gaithersburg, Maryland.

Market cap$425.6M
Employees900
Emergent BioSolutions Inc. competitors & alternatives →
Euronet Worldwide, Inc.EEFT · FintechLeawood, United States
Public

Euronet Worldwide, Inc. delivers a comprehensive suite of payment and transaction processing and distribution services globally. Their clientele spans financial institutions, agents, retailers, merchants, content providers, and individual consumers. The company operates through three core divisions: Electronic Fund Transfer (EFT) Processing: This segment offers electronic payment solutions including ATM cash withdrawal and deposit facilities, network participation for ATMs, outsourced management of ATMs and point-of-sale (POS) systems, and services related to credit and debit cards such as outsourcing, issuing, and merchant acquiring. Additional offerings encompass ATM and POS currency conversion, surcharge options, advertising, customer relationship management, mobile top-ups, bill payment, fraud prevention, international money remittance, cardless payouts, banknote recycling, and tax-refund services. It also provides integrated financial transaction software and distributes non-cash products, supported by a network of 42,713 ATMs and roughly 438,000 POS terminals. epay: Focusing on prepaid products, this division manages the distribution and processing of prepaid mobile airtime and other electronic payment solutions. It also handles payment processing for various prepaid products, cards, services, vouchers, physical gift fulfillment, and gift card distribution and processing. This network extends across approximately 775,000 POS terminals. Money Transfer: This segment facilitates diverse money movement services, including direct consumer-to-consumer and account-to-account transfers, customer bill payment, check cashing, and foreign currency exchange. They also provide mobile top-up services, cash management, foreign currency risk management, and alternative payment solutions like money orders and prepaid debit cards. This division benefits from an extensive network of approximately 510,000 money transfer locations. Established in 1994 as Euronet Services, Inc., the company adopted its current name, Euronet Worldwide, Inc., in August 2001 and maintains its headquarters in Leawood, Kansas.

Market cap$2.4B
Employees10,800
Euronet Worldwide, Inc. competitors & alternatives →
FS Bancorp, Inc.FSBW · BankingMountlake Terrace, United States
Public

FS Bancorp, Inc. functions as the holding company for 1st Security Bank of Washington, delivering a comprehensive suite of banking and financial services. These offerings cater to families, local and regional businesses, and specialized industry sectors. The company operates through two main divisions: Commercial and Consumer Banking, and Home Lending. Its deposit portfolio includes checking, money market, and savings accounts, alongside certificates of deposit. For lending, FS Bancorp provides diverse options such as first and second mortgages for one-to-four-family residences, home equity loans, non-mortgage commercial business loans, commercial real estate and construction/development financing, and a variety of consumer loans including personal lines of credit, credit cards, auto, direct home improvement, deposit-secured, and recreational vehicle loans. As of December 31, 2021, the company maintained 21 full-service bank branches and 10 home loan production offices, strategically situated in suburban communities across the greater Puget Sound area (including Snohomish, King, Pierce, Jefferson, Kitsap, Clallam, Grays Harbor, Thurston, and Lewis counties), with an additional loan production office serving the Tri-Cities market. Established in 1936, FS Bancorp, Inc. is headquartered in Mountlake Terrace, Washington.

Market cap$346.8M
Employees567
FS Bancorp, Inc. competitors & alternatives →
Global Payments, Inc.GPN · FintechAtlanta, United States
Public

Global Payments Inc. is a prominent provider of payment technology and software solutions, facilitating transactions across various forms including card, electronic, check, and digital payments. Its operations span the Americas, Europe, and the Asia-Pacific regions. The company's business is structured into three primary divisions: Merchant Solutions, Issuer Solutions, and Business and Consumer Solutions. The Merchant Solutions segment offers a comprehensive array of services designed to support businesses in managing their payment processing. These services include transaction authorization, settlement, funding, customer support, chargeback resolution, terminal rental and deployment, robust payment security, consolidated billing, and online reporting. Furthermore, this segment delivers specialized enterprise software solutions that help customers in diverse vertical markets streamline their business operations. It also provides various value-added services, such as point-of-sale (POS) systems, analytics and engagement tools, and even payroll and human capital management services. The Issuer Solutions segment empowers financial institutions and retailers by providing them with platforms to efficiently manage their card portfolios. Additionally, it supplies commercial payment and ePayables solutions specifically for businesses and government entities. Through its Business and Consumer Solutions segment, operating notably under the Netspend brand, the company addresses the financial needs of the underbanked, other consumers, and various businesses. This segment's offerings comprise general-purpose reloadable prepaid debit cards, payroll cards, demand deposit accounts, and other related financial services. Global Payments distributes its products and services through a multifaceted sales and marketing approach, leveraging its direct sales force, trade association partnerships, agent and enterprise software provider networks, referral arrangements with value-added resellers, and independent sales organizations. Founded in 1967, Global Payments Inc. is headquartered in Atlanta, Georgia.

Market cap$21.5B
Employees26,000
Global Payments, Inc. competitors & alternatives →
Ranger Energy Services, Inc.RNGR · Oil & GasHouston, United States
Public

Ranger Energy Services, Inc., founded in 2014 and based in Houston, Texas, delivers crucial onshore support to exploration and production companies throughout the United States. The company's operations are categorized into three main segments: High Specification Rigs, Wireline Services, and Processing Solutions and Ancillary Services. The High Specification Rigs division operates a fleet of 540 advanced well service rigs and accompanying equipment. These assets are vital for facilitating various operations across a well's lifespan, including essential maintenance. The Wireline Services segment offers comprehensive solutions aimed at identifying and resolving well production challenges. This includes wireline production and intervention services, covering cased hole logging, perforating, mechanical work, and pipe recovery. Additionally, it provides wireline completion services, primarily for pump-down perforating to create entry holes in the production casing, alongside general pumping services. This segment is supported by 68 wireline units and four high-pressure pump trucks. Finally, the Processing Solutions and Ancillary Services segment provides a diverse range of specialized support. This includes the rental of well service-related equipment such as fluid pumps, power swivels, well control packages, hydraulic catwalks, frac tanks, pipe racks, and pipe handling tools. The segment also offers decommissioning, fluid management, coil tubing, and snubbing services. Furthermore, it supplies proprietary and modular equipment for natural gas processing, and manages the rental, installation, commissioning, startup, operation, and maintenance of mechanical refrigeration units, nitrogen gas liquid stabilizer units, nitrogen gas liquid storage units, and related equipment.

Market cap$373.3M
Employees1,950
Ranger Energy Services, Inc. competitors & alternatives →
RBB BancorpRBB · BankingLos Angeles, United States
Public

RBB Bancorp, founded in 2008 and headquartered in Los Angeles, California, functions as the parent entity for Royal Business Bank. The bank specializes in offering a comprehensive suite of financial products and banking services primarily to the Chinese-American, Korean-American, and other Asian-American populations. Its deposit offerings include checking, savings, and money market accounts, along with certificates of deposit. For lending, RBB Bancorp provides commercial and industrial lines of credit, term loans, mortgage warehouse facilities, and international trade discount financing. The institution also funds commercial real estate transactions, residential and commercial development, land acquisition, and construction projects, alongside offering Small Business Administration (SBA) loans and single-family residential mortgages. Furthermore, the bank delivers international banking services such as letters of credit, SWIFT transfers, export advisory, trade finance discounts, and foreign exchange. Modern conveniences like remote deposit, online banking, and mobile banking are also available. Its diverse client base spans individuals, businesses, municipalities, and various other organizations. As of December 31, 2021, RBB Bancorp maintained a network of 23 branch locations, situated in the Western region across Los Angeles, Orange, and Ventura Counties in California, Clark County in Nevada, and Honolulu, Hawaii, as well as in the Eastern region, including Manhattan, Brooklyn, and Queens in New York, Chicago, Illinois, and Edison, New Jersey.

Market cap$445.1M
Employees372
RBB Bancorp competitors & alternatives →
SELECTIS HEALTH, INC.GBCS · PharmaceuticalsDenver, United States
Public

Selectis Health, Inc., formerly known as Global Healthcare REIT, Inc., was originally established with the intention of operating as a real estate investment trust (REIT) focused on investments in healthcare-related real estate and assets. Over time, the company's strategic emphasis has shifted; rather than primarily leasing nursing home properties to independent operators, it now increasingly owns and directly manages its real estate holdings. Consequently, the organization no longer plans to pursue or maintain its REIT qualification. It is also actively exploring a change of its corporate name and other foundational charter amendments to more accurately represent its revised business model. Historically, before adopting the name Global Healthcare REIT, Inc. on September 30, 2013, the company operated as Global Casinos, Inc., managing two gaming facilities. On that pivotal date, Global Casinos, Inc. divested these gaming operations through a split-off and sale. This move coincided with the acquisition of West Paces Ferry Healthcare REIT, Inc. (WPF) in a transaction structured as a reverse acquisition, where WPF was considered the accounting acquirer. Presently, the company's core activities involve the acquisition, development, leasing, management, and eventual disposition of real estate assets within the healthcare industry. It also extends financing solutions to healthcare providers. As of September 30, 2020, the company's portfolio comprised twelve healthcare properties. These assets are either leased or managed by independent third-party operators under triple-net lease agreements, or they are directly managed and operated by the company itself. The organization makes a strategic decision to operate facilities internally when it determines such an approach to be most beneficial and efficient.

Market cap$17.6M
Employees616
SELECTIS HEALTH, INC. competitors & alternatives →
Targa Resources0LD9 · Oil & GasHouston, United States
Public

Targa Resources Corp., along with its affiliated entity, Targa Resources Partners LP, operates as a prominent North American midstream energy enterprise. Its business encompasses the ownership, management, procurement, and expansion of essential energy infrastructure. The company's activities are broadly categorized into two key divisions: Gathering and Processing, and Logistics and Transportation. Within its operations, Targa undertakes a comprehensive array of services for natural gas, including its collection, compression, purification, processing, conveyance, and final distribution. Similarly, for natural gas liquids (NGLs) and their derivatives, it provides storage, fractionation, treatment, transportation, and sales services, extending its support to liquefied petroleum gas (LPG) exporters. The firm also handles crude oil through gathering, storage, terminal operations, purchasing, and sales. Furthermore, its logistics functions involve the acquisition and resale of NGL products, alongside the wholesale distribution of propane. This includes offering associated logistical support to a diverse clientele, ranging from multi-state and independent retailers to various other end-users. Targa additionally delivers NGL balancing solutions and transportation pathways for refineries and petrochemical facilities situated in the Gulf Coast region. It also actively procures, markets, and resells natural gas. The company's extensive infrastructure network features approximately 28,400 miles of natural gas pipelines and 42 owned or operated processing plants. It possesses or manages a total of 34 underground storage wells, boasting a substantial gross capacity of about 76 million barrels. As of December 31, 2021, Targa's assets further comprised the leasing and management of roughly 648 railcars, 119 transport tractors, and two company-owned pressurized NGL barges. Established in 2005, the corporation maintains its headquarters in Houston, Texas.

Market cap$64.5B
Employees3,570
Targa Resources competitors & alternatives →
Xencor, Inc.XNCR · BiotechnologyPasadena, United States
Public

Xencor Inc., a biopharmaceutical firm headquartered in Monrovia, California, and established in 1997, operates as a clinical-stage entity. Its central mission involves the discovery and sophisticated engineering of monoclonal antibody and cytokine therapeutics, primarily aimed at treating patients afflicted with cancer and autoimmune disorders. The company is associated with several notable therapies currently in use, such as Sotrovimab, which targets the SARS-CoV-2 virus; Ultomiris, prescribed for paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome; and Monjuvi, indicated for individuals with relapsed or refractory diffuse large B-cell lymphoma. Xencor maintains a robust and diverse pipeline of drug candidates advancing through various clinical trial stages. In oncology, this includes Plamotamab, a tumor-targeted antibody, currently undergoing Phase I trials for non-Hodgkin lymphoma; Vudalimab, a bispecific antibody in Phase II for metastatic castration-resistant prostate cancer and other solid tumor types; and Tidutamab, also in Phase II for neuroendocrine tumors. Further cancer-focused programs comprise XmAb306, XmAb104, and XmAb841, all in Phase I for selected solid tumors; AMG 509, in Phase I for prostate cancer; XmAb819, being developed for renal cell carcinoma; and a program involving Novartis XmAb. In the infectious disease arena, Xencor is progressing VIR-3434 through Phase II for hepatitis B virus infection; VIR-2482 in Phase 1/2 for influenza A; VIR-7832 in a Phase 1b/2a trial for mild-to-moderate COVID-19; and is involved in the Phase 2/3 NIH ACTIV-2 trial for COVID-19 with BMS-986414 + BMS-986413. Beyond these, the company is developing XmAb564, a Phase I candidate for autoimmune diseases; Obexelimab, also for autoimmune conditions; AIMab7195, designed to reduce IgE levels for allergic responses; and Xpro1595, an experimental treatment for Alzheimer's disease, mild cognitive impairment, and depression. Xencor also holds a licensing agreement with Caris Life Sciences.

Market cap$1.5B
Employees260
Xencor, Inc. competitors & alternatives →

Company intelligence, live

Profiles, competitors, funding, the investor graph, hiring signals, tech stacks, leadership and corporate events — for every company that matters, continuously updated.

Subscribe to Xcout Intel →